2,5-Dimethoxy-4-iodoamphetamine


2,5-Dimethoxy-4-iodoamphetamine (DOI) is a psychedelic drug and a substituted amphetamine. It is known for its hallucinogenic properties and is used primarily in scientific research.
Chemical Properties[edit]
2,5-Dimethoxy-4-iodoamphetamine is a member of the phenethylamine and amphetamine chemical classes. Its chemical formula is C11H16INO2. The compound features a methoxy group at the 2 and 5 positions of the phenyl ring and an iodine atom at the 4 position.
Pharmacology[edit]
DOI acts primarily as a serotonin receptor agonist, with a high affinity for the 5-HT2A receptor. This interaction is responsible for its psychedelic effects. The compound is known to induce alterations in perception, mood, and cognition, similar to other psychedelic substances.
Effects[edit]
The effects of DOI can include visual and auditory hallucinations, altered sense of time, and changes in thought processes. The onset of effects typically occurs within 30 to 60 minutes after ingestion, with a duration of action lasting up to 16 hours.
Uses[edit]
While DOI is not commonly used recreationally due to its long duration and intense effects, it is utilized in scientific research to study the serotonin system and the effects of psychedelics on the brain. It is also used in receptor binding studies to understand the interaction of drugs with the 5-HT2A receptor.
Legal Status[edit]
The legal status of DOI varies by country. In some jurisdictions, it is classified as a controlled substance, while in others, it may be legal for research purposes.
Related Compounds[edit]
DOI is structurally related to other psychedelic amphetamines such as 2,5-Dimethoxy-4-bromoamphetamine (DOB) and 2,5-Dimethoxy-4-ethylamphetamine (DOET). These compounds share similar pharmacological profiles and effects.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian